Double-blind Trial of Propranolol (inderal) in Angina of Effort.

Double-blind Trial of Propranolol (inderal) in Angina Pectoris.

Comparison of Propranolol and Inderal L.A. in Patients with Angina

TWELVE patients with moderately severe angina pectoris completed a double blind cross-over comparison of conventional propranolol (40 mg q.i.d.) and Inderal L.A. (160 mg once daily) with regard to therapeutic effectiveness, blood levels, compliance and patient acceptability.Exercise tolerance was assessed using standardised treadmill testing at 1, 2, 4, 8, 12 and 24 hours after the morning dose...

Use of Propranolol (inderal) in Treatment of Hypertension.

Angina of Effort-Srivastava et al. BWDIHLJOURNAL 725 obtained in the final 14 days of each 21-day period. The patients' own general assessment of each treatment is based upon the whole 21-day periods and scored on a five-point scale in the following way:-1 worsening of the angina; + 1, + 2, and +3 indicating slight, moderate, and marked improvement respectively; and 0 showing that the condition...

A double-blind randomized trial of propranolol and verapamil in the treatment of effort angina.

In 18 patients with stable effort angina, verapamil, 80 mg four times daily, was compared with propranolol, 80 mg four times daily, in a double-blind, placebo-controlled trial to assess the effects on anginal threshold, exercise capacity and left ventricular function measured by gated equilibrium blood pool scanning. Both propranolol and verapamil improved exercise capacity (placebo 424 +/- 135...

Beneficial effects of diltiazem and propranolol, alone and in combination, in patients with stable angina pectoris.

The antianginal effects of diltiazem 180 mg/day and propranolol 240 mg/day, alone and in combination, were investigated in 15 patients with effort related angina in a double blind placebo controlled crossover trial, with each period of treatment lasting four weeks. Patients performed a symptom limited treadmill exercise test at the end of each period of treatment. Mean (SEM) time to onset of an...